Dyne TherapeuticsInc Current Ratio vs. Total Asset
| DYN Stock | USD 31.88 0.68 2.18% |
Current Ratio | First Reported 2010-12-31 | Previous Quarter 2.53204815 | Current Value 4.74 | Quarterly Volatility 7.73603187 |
For Dyne TherapeuticsInc profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Dyne TherapeuticsInc to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Dyne TherapeuticsInc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Dyne TherapeuticsInc's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Dyne TherapeuticsInc over time as well as its relative position and ranking within its peers.
Dyne |
Is Dyne TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne TherapeuticsInc. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.98) | Return On Assets (0.41) | Return On Equity (0.71) |
The market value of Dyne TherapeuticsInc is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Dyne TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne TherapeuticsInc's market value can be influenced by many factors that don't directly affect Dyne TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Dyne TherapeuticsInc Total Asset vs. Current Ratio Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Dyne TherapeuticsInc's current stock value. Our valuation model uses many indicators to compare Dyne TherapeuticsInc value to that of its competitors to determine the firm's financial worth. Dyne TherapeuticsInc is rated # 2 in current ratio category among related companies. It is rated # 2 in total asset category among related companies fabricating about 14,194,497 of Total Asset per Current Ratio. At this time, Dyne TherapeuticsInc's Current Ratio is very stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value Dyne TherapeuticsInc by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Dyne TherapeuticsInc's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Dyne TherapeuticsInc's earnings, one of the primary drivers of an investment's value.Dyne Total Asset vs. Current Ratio
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Dyne TherapeuticsInc |
| = | 11.63 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Dyne TherapeuticsInc |
| = | 165.08 M |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Dyne Total Asset Comparison
Dyne TherapeuticsInc is currently under evaluation in total asset category among related companies.
Dyne TherapeuticsInc Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Dyne TherapeuticsInc, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Dyne TherapeuticsInc will eventually generate negative long term returns. The profitability progress is the general direction of Dyne TherapeuticsInc's change in net profit over the period of time. It can combine multiple indicators of Dyne TherapeuticsInc, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -656.6 K | -689.5 K | |
| Operating Income | -242.2 M | -230.1 M | |
| Income Before Tax | -235.9 M | -247.7 M | |
| Total Other Income Expense Net | 6.2 M | 6.5 M | |
| Net Loss | -235.9 M | -247.7 M | |
| Income Tax Expense | -3.3 M | -3.5 M | |
| Net Interest Income | 7.2 M | 7.6 M | |
| Interest Income | 7.2 M | 7.6 M | |
| Net Loss | -208.1 M | -197.7 M | |
| Net Loss | -151.3 M | -143.7 M | |
| Change To Netincome | 20.9 M | 21.9 M | |
| Net Loss | (3.95) | (4.15) | |
| Income Quality | 0.80 | 0.71 | |
| Net Income Per E B T | 1.13 | 0.79 |
Dyne Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Dyne TherapeuticsInc. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Dyne TherapeuticsInc position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Dyne TherapeuticsInc's important profitability drivers and their relationship over time.
Use Dyne TherapeuticsInc in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dyne TherapeuticsInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne TherapeuticsInc will appreciate offsetting losses from the drop in the long position's value.Dyne TherapeuticsInc Pair Trading
Dyne TherapeuticsInc Pair Trading Analysis
The ability to find closely correlated positions to Dyne TherapeuticsInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dyne TherapeuticsInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dyne TherapeuticsInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dyne TherapeuticsInc to buy it.
The correlation of Dyne TherapeuticsInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dyne TherapeuticsInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dyne TherapeuticsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dyne TherapeuticsInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Dyne TherapeuticsInc position
In addition to having Dyne TherapeuticsInc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Millennials Best Thematic Idea Now
Millennials Best
Companies or funds that provide products or services that appeal to the generation of millennials and that are expected to experience growth in the next 5 years. The millennial generation usually refers to the demographic population that were born between 1980 to 2000. The Millennials Best theme has 77 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Millennials Best Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Investing Opportunities. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne TherapeuticsInc guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
Complementary Tools for Dyne Stock analysis
When running Dyne TherapeuticsInc's price analysis, check to measure Dyne TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dyne TherapeuticsInc is operating at the current time. Most of Dyne TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Dyne TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dyne TherapeuticsInc's price. Additionally, you may evaluate how the addition of Dyne TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |
To fully project Dyne TherapeuticsInc's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Dyne TherapeuticsInc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Dyne TherapeuticsInc's income statement, its balance sheet, and the statement of cash flows.